COVID-19 and multisystem inflammatory syndrome in children and adolescents

Li Jiang, Kun Tang, Mike Levin, Omar Irfan, Shaun K. Morris, Karen Wilson, Jonathan D. Klein, Zulfiqar A. Bhutta

Research output: Contribution to journalReview articlepeer-review

559 Citations (Scopus)


As severe acute respiratory syndrome coronavirus 2 continues to spread worldwide, there have been increasing reports from Europe, North America, Asia, and Latin America describing children and adolescents with COVID-19-associated multisystem inflammatory conditions. However, the association between multisystem inflammatory syndrome in children and COVID-19 is still unknown. We review the epidemiology, causes, clinical features, and current treatment protocols for multisystem inflammatory syndrome in children and adolescents associated with COVID-19. We also discuss the possible underlying pathophysiological mechanisms for COVID-19-induced inflammatory processes, which can lead to organ damage in paediatric patients who are severely ill. These insights provide evidence for the need to develop a clear case definition and treatment protocol for this new condition and also shed light on future therapeutic interventions and the potential for vaccine development. Translations: For the French, Chinese, Arabic, Spanish and Russian translations of the abstract see Supplementary Materials section.

Original languageEnglish
Pages (from-to)e276-e288
JournalThe Lancet Infectious Diseases
Issue number11
Publication statusPublished - Nov 2020


Dive into the research topics of 'COVID-19 and multisystem inflammatory syndrome in children and adolescents'. Together they form a unique fingerprint.

Cite this